Cytokinetics

-$0.45 (-1.26%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.

About CYTK

Cytokinetics, Inc. operates as a biopharmaceutical company. The firm focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases.

CEO
Robert I. Blum
Employees
184
Headquarters
South San Francisco, California
Founded
1997

CYTK Key Statistics

Market Cap
2.95B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
795.83K
High Today
$36.24
Low Today
$35.09
Open Price
$35.89
Volume
597.34K
52 Week High
$39.46
52 Week Low
$14.89

CYTK News

Simply Wall StOct 15

Cytokinetics' investors will be pleased with their massive 390% return over the last three years

Investing can be hard but the potential fo an individual stock to pay off big time inspires us. But when you hold the right stock for the right time period, the

CYTK Earnings

-$0.86
-$0.57
-$0.29
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure